| |||
Names | |||
---|---|---|---|
Preferred IUPAC name 2-Methylnaphthalene-1,4-diol | |||
Other names 2-Methyl-1,4-naphthalenediol; 2-Methyl-1,4-dihydroxynaphthalene | |||
Identifiers | |||
3D model (JSmol) | |||
ChemSpider | |||
ECHA InfoCard | 100.006.886 | ||
PubChem CID | |||
UNII | |||
CompTox Dashboard (EPA) | |||
| |||
| |||
Properties | |||
C11H10O2 | |||
Molar mass | 174.199 g·mol−1 | ||
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Menadiol is an organic compound with the formula C6H4(COH)2(CH)(CH3). It is formally a derivative of p-hydroquinone. The name vitamin K4 can refer to:
Menadiol sodium diphosphate is approved in the UK for treatment and prevention of haemorrhage, mainly in obstructive jaundice (before and after surgery). [6] Unlike natural, lipophilic forms of vitamin K, menadiol sodium diphosphate does not require bile for absorption, hence the use in obstructive jaundice. A disadvantage is that it takes 24 hours to show effects, though the effects do last for several days. It can cause hemolytic anemia and is contraindicated in glucose 6-phosphate dehydrogenase deficiency. [7]
Menadiol is probably naturally produced by reduction of menadione ("vitamin K3"; see Quinone § Reduction) as an intermediate in the conversion from K3 to MK-4. [8] It can be oxidized in experimental conditions back to menadione. [9]